Actively Recruiting
Baroloop Multicenter Trial (Baroloop MCT)
Led by neuroloop GmbH · Updated on 2025-04-17
120
Participants Needed
4
Research Sites
392 weeks
Total Duration
On this page
Sponsors
N
neuroloop GmbH
Lead Sponsor
A
Avania
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn weather the baroloop system is safe and works to treat hypertension in adults that do not respond sufficiently to medication. The main questions it aims to answer are: * Is the baroloop device associated with any major medical problems including death? * Does the baroloop lower the blood pressure of study participants? Participants will be implanted with the baroloop device. Afterwards they will visit the clinic after 14 days, 3 months, 6 months, 12 months, 18 months, and 24 months for adjustment of the device settings and/or other study related assessments. Participants will also be asked to answer questions regarding their quality of life.
CONDITIONS
Official Title
Baroloop Multicenter Trial (Baroloop MCT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older.
- Persistent office systolic blood pressure (SBP) ≥ 140 mm Hg and diastolic blood pressure (DBP) > 90 mm Hg on antihypertensive medicines on two visits separated by at least four weeks.
- Mean 24-hour systolic ambulatory blood pressure monitoring (ABPM) ≥ 130 mm Hg and mean 24-hour diastolic ABPM ≥ 80 mm Hg after confirmed observed therapy.
- Stable drug regimen of three antihypertensive medicines including a renin-angiotensin blocker (ACE) or Angiotensin II Receptor Blocker (ARBs), a calcium channel blocker (CCB), and a diuretic for four weeks.
- Willingness and ability to comply with follow-up requirements.
- Signed informed consent.
You will not qualify if you...
- Limited access to the vagal nerve due to size incompatible with the baroloop cuff.
- History of injury to the vagus nerve or its branches.
- Secondary causes of hypertension.
- Estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73m2.
- Type 1 diabetes or poorly controlled type 2 diabetes (HbA1c > 10%).
- Need for chronic oxygen therapy or mechanical ventilation.
- Untreated sleep apnea (AHI > 15).
- Morbid obesity (Body Mass Index > 40 kg/m2) or arm circumference over 46 cm.
- Presence of pacemaker or implantable defibrillators.
- History of stroke or transient ischemic attack within six months before screening.
- Symptomatic carotid artery disease or significant carotid artery occlusion.
- Prior neck surgery, radiation, or scarring near carotid artery.
- Limited neck mobility due to vertebral disease or surgery.
- History of severe heart failure (NYHA class III-IV).
- Cardiac arrhythmias requiring anticoagulation that interfere with blood pressure measurement.
- Unexplained fainting in last six months.
- History of bleeding disorders or significant anemia (hemoglobin < 10 g/dl).
- Current anticoagulation therapy (except aspirin alone).
- History of unresolved drug or alcohol use.
- Active psychiatric treatment.
- Life expectancy under 12 months due to other diseases.
- Conditions precluding participation or follow-up compliance.
- Participation in another ongoing clinical study.
- Pregnancy.
- Resting heart rate under 45 beats per minute.
- Baroreflex failure or autonomic neuropathy.
- Uncontrolled bradyarrhythmias.
- Any grade of atrioventricular block.
- Presence of another vagus stimulator.
- Likely need for cervical MRI.
- Occupational exposure to high levels of non-ionizing radiation.
- Cognitive limitations affecting ability to follow procedures.
- Likely exposure to diathermy.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Clemenshospital Münster
Münster, North Rhine-Westphalia, Germany, 48153
Actively Recruiting
2
Marienhaus Klinikum Mainz
Mainz, Rhineland-Westphalia, Germany, 55131
Actively Recruiting
3
Städtisches Klinikum Dresden
Dresden, Saxony, Germany, 01067
Actively Recruiting
4
UMC Utrecht
Utrecht, Utrecht, Netherlands, 3584 CX
Actively Recruiting
Research Team
M
Medical Scientific Affairs
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here